Picture of Phaxiam Therapeutics SA logo

PHXM — Phaxiam Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: ERYTECH Pharma Reports Q1 Net Loss Of EUR 11.9 Million

May 12 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH PHARMA SA - NET LOSS FOR Q1 OF 2022 WAS EUR 11.9
MILLION

Source text for Eikon:  ID:nGNX8Vf0DM 
Further company coverage:  ERYP.PA 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Phaxiam Therapeutics SA

See all news